{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:16:11Z","timestamp":1778336171974,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s00380-020-01560-w","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T06:03:23Z","timestamp":1579673003000},"page":"957-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcome of carvedilol therapy in Japanese patients with nonischemic heart failure"],"prefix":"10.1007","volume":"35","author":[{"given":"Kimiko","family":"Nagara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-7196","authenticated-orcid":false,"given":"Tsuyoshi","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhisa","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"1560_CR1","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the U.S. Carvedilol Heart Failure Study Group (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349\u20131355","journal-title":"N Engl J Med"},{"key":"1560_CR2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL, for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651\u20131658","journal-title":"N Engl J Med"},{"key":"1560_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","unstructured":"CIBIS-II Investigators and Committees (1999) The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 353:9\u201313","journal-title":"Lancet"},{"key":"1560_CR4","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","volume":"353","author":"MERIT-HF Study Group","year":"1999","unstructured":"MERIT-HF Study Group (1999) Effect of metoprolol CR\/XL in chronic heart failure: metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 353:2001\u20132007","journal-title":"Lancet"},{"key":"1560_CR5","first-page":"e240","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL (2013) 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 128:e240\u2013e327","journal-title":"Circulation"},{"key":"1560_CR6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129\u20132200","journal-title":"Eur Heart J"},{"key":"1560_CR7","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","volume":"83","author":"H Tsutsui","year":"2019","unstructured":"Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, Kitakaze M, Kinugawa K, Kihara Y, Goto Y, Komuro I, Saiki Y, Saito Y, Sakata Y, Sato N, Sawa Y, Shiose A, Shimizu W, Shimokawa H, Seino Y, Node K, Higo T, Hirayama A, Makaya M, Masuyama T, Murohara T, Momomura SI, Yano M, Yamazaki K, Yamamoto K, Yoshikawa T, Yoshimura M, Akiyama M, Anzai T, Ishihara S, Inomata T, Imamura T, Iwasaki YK, Ohtani T, Onishi K, Kasai T, Kato M, Kawai M, Kinugasa Y, Kinugawa S, Kuratani T, Kobayashi S, Sakata Y, Tanaka A, Toda K, Noda T, Nochioka K, Hatano M, Hidaka T, Fujino T, Makita S, Yamaguchi O, Ikeda U, Kimura T, Kohsaka S, Kosuge M, Yamagishi M, Yamashina A, Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group (2019) JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure\u2014digest version. Circ J 83:2084\u20132184","journal-title":"Circ J"},{"key":"1560_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger VL (2013) Epidemiology of heart failure. Circ Res 113:646\u2013659","journal-title":"Circ Res"},{"key":"1560_CR9","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1177\/2047487317739079","volume":"24","author":"T Sato","year":"2017","unstructured":"Sato T, Yoshihisa A, Kanno Y, Suzuki S, Yamaki T, Sugimoto K, Kunii H, Nakazato K, Suzuki H, Saitoh SI, Ishida T, Takeishi Y (2017) Cardiopulmonary exercise testing as prognostic indicators: comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction. Eur J Prev Cardiol 24:1979\u20131987","journal-title":"Eur J Prev Cardiol"},{"key":"1560_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.amjcard.2017.12.012","volume":"121","author":"Y Hamatani","year":"2018","unstructured":"Hamatani Y, Nagai T, Shiraishi Y, Kohsaka S, Nakai M, Nishimura K, Kohno T, Nagatomo Y, Asaumi Y, Goda A, Mizuno A, Yasuda S, Ogawa H, Yoshikawa T, Anzai T, Investigators for the WET-NaDEF Collaboration Project (2018) Long-term prognostic significance of plasma B-type natriuretic peptide level in patients with acute heart failure with reduced, mid-range, and preserved ejection fractions. Am J Cardiol 121:731\u2013738","journal-title":"Am J Cardiol"},{"key":"1560_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ehf2.12418","volume":"6","author":"T Shiga","year":"2019","unstructured":"Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, Oka T, Tanaka H, Murasaki S, Yamauchi T, Katoh J, Hattori H, Kikuchi N, Watanabe E, Yamada Y, Haruki S, Kogure T, Suzuki T, Uetsuka Y, Hagiwara N, HIJ-HF II Investigators (2019) Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail 6:475\u2013486","journal-title":"ESC Heart Fail"},{"key":"1560_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"1560_CR13","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","volume":"342","author":"F Waagstein","year":"1993","unstructured":"Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A, for the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group (1993) Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441\u20131446","journal-title":"Lancet"},{"key":"1560_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ahj.2003.07.023","volume":"147","author":"M Hori","year":"2004","unstructured":"Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, MUCHA Investigators (2004) Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the multicenter carvedilol heart failure dose assessment (MUCHA) trial. Am Heart J 147:324\u2013330","journal-title":"Am Heart J"},{"key":"1560_CR15","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1253\/circj.CJ-09-0993","volume":"74","author":"M Tsuchihashi-Makaya","year":"2010","unstructured":"Tsuchihashi-Makaya M, Kinugawa S, Yokoshiki H, Hamaguchi S, Yokota T, Goto D, Takeshita A, Tsutsui H, JCARE-CARD Investigators (2010) Beta-blocker use at discharge in patients hospitalized for heart failure is associated with improved survival. Circ J 74:1364\u20131371","journal-title":"Circ J"},{"key":"1560_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1253\/circj.70.376","volume":"70","author":"Y Matsumura","year":"2006","unstructured":"Matsumura Y, Takata J, Kitaoka H, Kubo T, Baba Y, Hoshikawa E, Hamada T, Okawa M, Hitomi N, Sato K, Yamasaki N, Yabe T, Furuno T, Nishinaga M, Doi Y (2006) Long-term prognosis of dilated cardiomyopathy revisited: an improvement in survival over the past 20 years. Circ J 70:376\u2013383","journal-title":"Circ J"},{"key":"1560_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jchf.2015.10.008","volume":"4","author":"F Edelmann","year":"2016","unstructured":"Edelmann F, Musial-Bright L, Gelbrich G, Trippel T, Radenovic S, Wachter R, Inkrot S, Loncar G, Tahirovic E, Celic V, Veskovic J, Zdravkovic M, Lainscak M, Apostolovi\u0107 S, Neskovic AN, Pieske B, D\u00fcngen HD, CIBIS-ELD Investigators and Project Multicenter Trials in the Competence Network Heart Failure (2016) Tolerability and feasibility of beta-blocker titration in HFpEF versus HFrEF: insights from the CIBIS-ELD trial. JACC Heart Fail 4:140\u2013149","journal-title":"JACC Heart Fail"},{"key":"1560_CR18","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1253\/circj.CJ-09-0254","volume":"73","author":"M Tsuchihashi-Makaya","year":"2009","unstructured":"Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, Kato N, Takeshita A, Tsutsui H, JCARE-CARD Investigators (2009) Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD). Circ J 73:1893\u20131900","journal-title":"Circ J"},{"key":"1560_CR19","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1253\/circj.CJ-18-0073","volume":"82","author":"T Nagai","year":"2018","unstructured":"Nagai T, Yoshikawa T, Saito Y, Takeishi Y, Yamamoto K, Ogawa H, Anzai T, JASPER Investigators (2018) Clinical characteristics, management, and outcomes of Japanese patients hospitalized for heart failure with preserved ejection fraction\u2014a report from the japanese heart failure syndrome with preserved ejection fraction (JASPER) registry. Circ J 82:1534\u20131545","journal-title":"Circ J"},{"key":"1560_CR20","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, Mebazaa A, Lund L, Ambrosio GA, Coats AJ, Ferrari R, Ruschitzka F, Maggioni AP, Filippatos G (2017) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry. Eur J Heart Fail 19:1574\u20131585","journal-title":"Eur J Heart Fail"},{"key":"1560_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.amjcard.2010.11.033","volume":"107","author":"E Hoshikawa","year":"2011","unstructured":"Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL (2011) Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and \u03b2 blockers in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 107:1065\u20131070","journal-title":"Am J Cardiol"},{"key":"1560_CR22","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1253\/circj.CJ-09-0989","volume":"74","author":"M Konishi","year":"2010","unstructured":"Konishi M, Haraguchi G, Kimura S, Inagaki H, Kawabata M, Hachiya H, Hirao K, Isobe M (2010) Comparative effects of carvedilol vs bisoprolol for severe congestive heart failure. Circ J 74:1127\u20131134","journal-title":"Circ J"},{"key":"1560_CR23","doi-asserted-by":"publisher","first-page":"e1008","DOI":"10.1016\/S2214-109X(18)30306-1","volume":"6","author":"TK Teng","year":"2018","unstructured":"Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, Wander GS, Yap JJ, MacDonald MR, Xu CF, Chia YM, Shimizu W, ASIAN-HF investigators, Richards AM, Voors A, Lam CS (2018) Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Glob Health 6:e1008\u2013e1018","journal-title":"Lancet Glob Health"},{"key":"1560_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1056\/NEJM198903023200905","volume":"320","author":"HH Zhou","year":"1989","unstructured":"Zhou HH, Koshakji RP, Silberstein DJ, Wilkinson GR, Wood AJ (1989) Racial differences in drug response. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites. N Engl J Med 320:565\u2013570","journal-title":"N Engl J Med"},{"key":"1560_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/eurjhf\/hfs141","volume":"15","author":"K Yamamoto","year":"2013","unstructured":"Yamamoto K, Origasa H, Hori M, J-DHF Investigators (2013) Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese diastolic heart failure study (J-DHF). Eur J Heart Fail 15:110\u2013118","journal-title":"Eur J Heart Fail"},{"key":"1560_CR26","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","volume":"94","author":"MR Bristow","year":"1996","unstructured":"Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N (1996) Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 94:2807\u20132816","journal-title":"Circulation"},{"key":"1560_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jacc.2012.03.023","volume":"60","author":"M Fiuzat","year":"2012","unstructured":"Fiuzat M, Wojdyla D, Kitzman D, Fleg J, Keteyian SJ, Kraus WE, Pi\u00f1a IL, Whellan D, O\u2019Connor CM (2012) Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction. J Am Coll Cardiol 60:208\u2013215","journal-title":"J Am Coll Cardiol"},{"key":"1560_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/ejhf.775","volume":"19","author":"S Paolillo","year":"2017","unstructured":"Paolillo S, Mapelli M, Bonomi A, Corr\u00e0 U, Piepoli M, Veglia F, Salvioni E, Gentile P, Lagioia R, Metra M, Limongelli G, Sinagra G, Cattadori G, Scardovi AB, Carubelli V, Scrutino D, Badagliacca R, Raimondo R, Emdin M, Magr\u00ec D, Correale M, Parati G, Caravita S, Spadafora E, Re F, Cicoira M, Frigerio M, Bussotti M, Min\u00e0 C, Oliva F, Battaia E, Belardinelli R, Mezzani A, Pastormerlo L, Di Lenarda A, Passino C, Sciomer S, Iorio A, Zambon E, Guazzi M, Pacileo G, Ricci R, Contini M, Apostolo A, Palermo P, Clemenza F, Marchese G, Binno S, Lombardi C, Passantino A, Perrone Filardi P, Agostoni P (2017) Prognostic role of \u03b2-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail 19:904\u2013914","journal-title":"Eur J Heart Fail"},{"key":"1560_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijcard.2012.11.051","volume":"164","author":"H Okamoto","year":"2013","unstructured":"Okamoto H, Hori M, Matsuzaki M, Tsutsui H, Yamazaki T, Nagai R, Yoshikawa T, Fujio Y, Nonen S, Azuma J, Izumi T, Ohashi Y, Kitabatake A, J-CHF Investigators (2013) Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study. Int J Cardiol 164:238\u2013244","journal-title":"Int J Cardiol"},{"key":"1560_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","volume":"27","author":"SJ Pocock","year":"2006","unstructured":"Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB (2006) Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27:65\u201375","journal-title":"Eur Heart J"},{"key":"1560_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","volume":"150","author":"FA McAlister","year":"2009","unstructured":"McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW (2009) Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 150:784\u2013794","journal-title":"Ann Intern Med"},{"key":"1560_CR32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","volume":"24","author":"JG Cleland","year":"2003","unstructured":"Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J, Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology (2003) The EuroHeart failure survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442\u2013463","journal-title":"Eur Heart J"},{"key":"1560_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00392-012-0467-8","volume":"102","author":"M B\u00f6hm","year":"2013","unstructured":"B\u00f6hm M, Borer J, Ford I, Gonzalez-Juanatey JR, Komajda M, Lopez-Sendon J, Reil JC, Swedberg K, Tavazzi L (2013) Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clin Res Cardiol 102:11\u201322","journal-title":"Clin Res Cardiol"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-020-01560-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01560-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:34:28Z","timestamp":1611189268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-020-01560-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1560"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01560-w","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"24 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Shiga and Dr Hagiwara received research funding and lecture fees from Daiichi-Sankyo. The other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}